Pulmonary haemodynamics by echocardiography over 3 days of acclimatization in lowlanders with chronic obstructive pulmonary disease travelling to 3100 m of high altitude

Aims Patients with chronic obstructive pulmonary disease experience an increase in systolic pulmonary artery pressure (sPAP) when exposed to high altitude with an unclear acclimatization. We investigated the effects of acute ascent to 3100 m on pulmonary haemodynamics of patients with chronic obstructive pulmonary disease and their acclimatization during a 3-day stay at high altitude. Methods and results In this prospective, interventional study, stable, normocapnic patients with chronic obstructive pulmonary disease, with FEV1 40–80%predicted and SpO2 ≥ 92%, residing at low altitude and staying for 3 days/nights at 3100 m without adverse events, were included. Echocardiography was performed at 760 m, directly after arrival at 3100 m (HA1) and the two following days (HA2/HA3). The primary outcome was the change in sPAP at different time points. Additionally, cardiac output (CO), tricuspid annular plane systolic excursion (TAPSE), and other echocardiographic parameters were measured. Thirty-eight patients with chronic obstructive pulmonary disease (37% females), aged (mean ± SD) 55 ± 10years, with FEV1 63 ± 12%predicted, were included. After acute ascent to 3100 m vs. 760 m, sPAP increased by 12 mmHg [95% confidence interval (CI): 9–15, P < 0.001], total pulmonary resistance (sPAP/CO) increased by 2 WU (1–3, P = 0.001), and TAPSE/sPAP decreased by −0.6 mm/mmHg (−0.9 to −0.2, P = 0.002). Right atrial pressure and CO were unchanged. At HA3 compared to HA1, sPAP decreased by −4 mmHg (−7 to −1, P = 0.008); no significant changes in further echocardiographic parameters were observed. Conclusion In stable patients with chronic obstructive pulmonary disease travelling to and staying at 3100 m for 3 days/nights without adverse events, sPAP initially increased, along with an increased pulmonary resistance and a reduced right ventricular-arterial coupling reflected by a lower TAPSE/sPAP. Whereas sPAP steadily decreased during acclimatization, other echocardiographic parameters remained unchanged.

Authors

Publication Details

Journal
Universität Zürich, ZORA
Published
2025-03-01
DOI
https://doi.org/10.5167/uzh-281995
Primary Topic
High Altitude and Hypoxia
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulmonary haemodynamics by echocardiography over 3 days of acclimatization in lowlanders with chronic obstructive pulmonary disease travelling to 3100 m of high altitude

Julian Müller, Konrad E. Bloch, Felix Christoph Tanner, Adilet Omuralieva et al.
Universität Zürich, ZORA
High Altitude and Hypoxia
article

Pulmonary haemodynamics by echocardiography over 3 days of acclimatization in lowlanders with chronic obstructive pulmonary disease travelling to 3100 m of high altitude

Julian Müller, Konrad E. Bloch, Felix Christoph Tanner, Adilet Omuralieva, Silvia Ulrich, Mona Lichtblau, Konstantinos Bitos, Talant M. Sooronbaev, Simon R. Schneider, Stéphanie Saxer, Maamed Mademilov
article en

Abstract

Aims Patients with chronic obstructive pulmonary disease experience an increase in systolic pulmonary artery pressure (sPAP) when exposed to high altitude with an unclear acclimatization. We investigated the effects of acute ascent to 3100 m on pulmonary haemodynamics of patients with chronic obstructive pulmonary disease and their acclimatization during a 3-day stay at high altitude. Methods and results In this prospective, interventional study, stable, normocapnic patients with chronic obstructive pulmonary disease, with FEV1 40–80%predicted and SpO2 ≥ 92%, residing at low altitude and staying for 3 days/nights at 3100 m without adverse events, were included. Echocardiography was performed at 760 m, directly after arrival at 3100 m (HA1) and the two following days (HA2/HA3). The primary outcome was the change in sPAP at different time points. Additionally, cardiac output (CO), tricuspid annular plane systolic excursion (TAPSE), and other echocardiographic parameters were measured. Thirty-eight patients with chronic obstructive pulmonary disease (37% females), aged (mean ± SD) 55 ± 10years, with FEV1 63 ± 12%predicted, were included. After acute ascent to 3100 m vs. 760 m, sPAP increased by 12 mmHg [95% confidence interval (CI): 9–15, P < 0.001], total pulmonary resistance (sPAP/CO) increased by 2 WU (1–3, P = 0.001), and TAPSE/sPAP decreased by −0.6 mm/mmHg (−0.9 to −0.2, P = 0.002). Right atrial pressure and CO were unchanged. At HA3 compared to HA1, sPAP decreased by −4 mmHg (−7 to −1, P = 0.008); no significant changes in further echocardiographic parameters were observed. Conclusion In stable patients with chronic obstructive pulmonary disease travelling to and staying at 3100 m for 3 days/nights without adverse events, sPAP initially increased, along with an increased pulmonary resistance and a reduced right ventricular-arterial coupling reflected by a lower TAPSE/sPAP. Whereas sPAP steadily decreased during acclimatization, other echocardiographic parameters remained unchanged.

Universität Zürich, ZORA
Good health and well-being
Openalex Percentile: Top 22%
High Altitude and Hypoxia
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.